180 Life Sciences Corp. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
180 Life Sciences Corp. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • 180 Life Sciences Corp. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $142K.
  • 180 Life Sciences Corp. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $3.24M.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2023 was -$8.81M, a 59.5% increase from 2022.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2022 was -$21.8M, a 363% decline from 2021.
  • 180 Life Sciences Corp. annual Nonoperating Income (Expense) for 2021 was -$4.71M, a 10.5% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$8.81M +$13M +59.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 -$21.8M -$17.1M -363% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$4.71M +$550K +10.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$5.26M -$716K -15.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$4.54M Jan 1, 2019 Dec 31, 2019 10-K 2021-07-09
2017 $663K Jan 1, 2017 Dec 31, 2017 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.